-
- 抗原 See all EDEM2 抗体
- EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
-
抗原表位
- AA 22-300
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This EDEM2 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human ER degradation-enhancing alpha-mannosidase-like protein 2 protein (22-300AA)
- 亚型
- IgG
- Top Product
- Discover our top product EDEM2 Primary Antibody
-
anti-ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) (AA 479-578) antibody
EDEM2 适用: 人 ELISA, WB, IHC (p), IP 宿主: 小鼠 Monoclonal 2E4 unconjugated
anti-ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) (AA 479-579) antibodyEDEM2 适用: 人 ELISA, WB, IHC, IHC (p) 宿主: 小鼠 Monoclonal 2E4 unconjugated
anti-ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) (AA 399-578) antibodyEDEM2 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) (AA 101-200) antibodyEDEM2 适用: 人 ELISA, WB, IF (cc), IF (p), IHC (p), IHC (fro), ICC 宿主: 兔 Polyclonal unconjugated
anti-ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) (AA 1-578) antibodyEDEM2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Recommended dilution: IHC:1:20-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- EDEM2 (ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2))
- 别名
- EDEM2 (EDEM2 产品)
- 别名
- C20orf31 antibody, C20orf49 antibody, bA4204.1 antibody, 9530090G24Rik antibody, AI327354 antibody, RGD1303074 antibody, MGC88910 antibody, DKFZp459A0314 antibody, ER degradation enhancing alpha-mannosidase like protein 2 antibody, ER degradation enhancer, mannosidase alpha-like 2 antibody, EDEM2 antibody, Edem2 antibody, edem2 antibody
- 背景
-
Background: Initiates the endoplasmic reticulum-associated degradation (ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2 (PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.
Aliases: bA4204.1 antibody, C20orf31 antibody, C20orf49 antibody, EDEM 2 antibody, EDEM2 antibody, EDEM2_HUMAN antibody, ER degradation enhancer mannosidase alpha like 2 antibody, ER degradation enhancing alpha mannosidase like 2 antibody, ER degradation enhancing alpha mannosidase like protein 2 antibody, ER degradation enhancing mannosidase like protein 2 antibody, ER degradation-enhancing alpha-mannosidase-like 2 antibody, FLJ10783 antibody, UNQ573/PRO1135 antibody
- UniProt
- Q9BV94
-
You are here:
